Antiarrhythmics or Ablation for Ventricular Tachycardia 2

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 416 participants.

Also called NCT02830360

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 416 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02830360
Other papers using this trial's data
  • A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial American heart journal, 2024-08 DOI, PubMed 38649085
  • Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia The New England journal of medicine, 2025-02-20 DOI, PubMed 39555820
  • Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia: A Substudy of the VANISH2 Trial Journal of the American College of Cardiology, 2026-01-20 DOI, PubMed 41217320

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Canada, France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02830360. Randomized; no masking; primary purpose treatment. Start 2016-10 (actual); primary completion 2024-06-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Antiarrhythmics or Ablation for Ventricular Tachycardia 2
Acronym
VANISH2
Condition
Ventricular Tachycardia (VT)
Intervention (Drug)
Antiarrythmic Drug Therapy
Intervention (Procedure)
Catheter ablation
Lead sponsor
John Sapp (class: other)
Collaborator
Heart and Stroke Foundation of Canada (class: other)
Collaborator
Abbott Medical Devices (class: industry)
Collaborator
Biosense Webster, Inc. (class: industry)
Collaborator
Ottawa Heart Institute Research Corporation (class: other)
Collaborator
Canadian Institutes of Health Research (CIHR) (class: other government)
Collaborator
Cardiac Arrhythmia Network of Canada (class: other)
Collaborator
Abbott (class: industry)
Collaborator
Nova Scotia Health Authority (class: other)

Record details

Record id
cardio:ct-nct02830360
Content hash
e9e492edb2e5b66ceb0c4964496149501da2f133522f7d2829d213420169a008